Manning Paul B
Insider CIK 1494695 · ABOS 10% owner · AVXS Director, 10% owner · VRCA Director, 10% owner · DOVA Director, 10% owner · TSHA Director, 10% owner · LQDA Director, 10% owner · CADL Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-09-30 | 2026-10-02 | 2,189 | $8.68 | $19.0K | 2,189 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-01 | 2,199 | $8.64 | $19.0K | 2,199 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2026-06-16 | 2026-06-18 | 5,882 | — | $0 | 475,465 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-06-04 | 2026-06-08 | 12,610 | $64.42 | $812.3K | 798,335 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-06-04 | 2026-06-08 | 11,513 | $63.13 | $726.8K | 804,798 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-06-04 | 2026-06-08 | 88,487 | $64.28 | $5.69M | 716,311 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-06-04 | 2026-06-08 | 68,265 | $63.83 | $4.36M | 810,945 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-06-04 | 2026-06-08 | 19,125 | $62.62 | $1.20M | 879,210 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-03-31 | 2026-04-02 | 4,618 | $4.11 | $19.0K | 4,618 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2026-02-23 | 2026-02-26 | 550,458 | $5.45 | $3.00M | 2,763,527 | SEC↗ |
| LQDA Liquidia Corp | J Other | 2026-02-11 | 2026-02-12 | 55,116 | $42.63 | $2.35M | 469,583 | SEC↗ |
| LQDA Liquidia Corp | J Other | 2026-02-11 | 2026-02-12 | 55,116 | $42.63 | $2.35M | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2025-11-25 | 2025-11-25 | 687,690 | — | $0 | 687,690 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2025-11-25 | 2025-11-25 | 343,845 | — | $0 | 343,845 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2025-11-25 | 2025-11-25 | 2,750,762 | $4.24 | $11.66M | 3,348,372 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2025-11-25 | 2025-11-25 | 1,375,380 | $4.24 | $5.83M | 3,958,189 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-09-02 | 2025-09-02 | 254,038 | $28.67 | $7.28M | 505,058 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-09-02 | 2025-09-02 | 74,230 | $29.14 | $2.16M | 430,828 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-08-29 | 2025-09-02 | 188,232 | $27.62 | $5.20M | 759,096 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-08-28 | 2025-09-02 | 154,337 | $27.94 | $4.31M | 947,328 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award | 2025-06-25 | 2025-06-26 | 1,070,663 | $4.67 | $5.00M | 2,213,069 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2025-06-17 | 2025-06-20 | 18,396 | — | $0 | 38,755 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2025-05-30 | 2025-06-03 | 750,000 | $2.75 | $2.06M | 2,841,704 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2024-12-16 | 2024-12-18 | 750,000 | $6.00 | $4.50M | 1,303,752 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2024-12-16 | 2024-12-18 | 500,000 | $6.00 | $3.00M | 1,142,406 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | G Gift | 2024-11-26 | 2024-11-26 | 450,000 | — | $0 | 25,828,094 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2024-11-22 | 2024-11-26 | 9,213,483 | — | $0 | 9,213,483 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2024-11-22 | 2024-11-26 | 9,213,483 | — | $0 | 9,213,483 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2024-11-22 | 2024-11-26 | 2,247,191 | — | $0 | 2,247,191 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2024-11-22 | 2024-11-26 | 2,247,191 | — | $0 | 2,247,191 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2024-11-22 | 2024-11-26 | 18,426,966 | — | $0 | 26,278,094 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2024-11-22 | 2024-11-26 | 4,494,382 | — | $0 | 5,976,101 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | G Gift | 2024-09-19 | 2024-09-23 | 2,675,611 | — | $0 | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | G Gift | 2024-09-19 | 2024-09-23 | 891,870 | — | $0 | 891,870 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | G Gift | 2024-09-19 | 2024-09-23 | 891,870 | — | $0 | 891,870 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | G Gift | 2024-09-19 | 2024-09-23 | 891,870 | — | $0 | 891,870 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2024-09-12 | 2024-09-16 | 337,078 | $8.90 | $3.00M | 816,311 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2024-06-27 | 2024-07-01 | 1,333,333 | $2.25 | $3.00M | 1,333,333 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2024-06-20 | 2024-06-24 | 20,359 | — | $0 | 299,689 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2023-12-14 | 2023-12-18 | 279,330 | $7.16 | $2.00M | 279,330 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2023-11-17 | 2023-11-20 | 100,000 | $1.63 | $163.0K | 16,566,667 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2023-08-16 | 2023-08-16 | 16,466,667 | $0.90 | $14.82M | 16,466,667 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2023-07-24 | 2023-07-24 | 200,000 | $5.02 | $1.00M | 7,851,128 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2023-06-19 | 2023-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-10-31 | 2022-11-02 | 1,500,000 | $2.00 | $3.00M | 1,642,202 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2022-07-05 | 2022-07-05 | 4,761,904 | $2.10 | $10.00M | 13,651,128 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 15,500 | — | $0 | 15,500 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-04-18 | 2022-04-19 | 392,156 | $5.10 | $2.00M | 392,156 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2022-03-31 | 2022-04-20 | 435,674 | — | $0 | 435,674 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-03 | 2022-02-04 | 50,000 | $7.84 | $392.0K | 142,202 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-03 | 2022-02-04 | 26,602 | $7.84 | $208.6K | 2,091,704 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-02 | 2022-02-04 | 45,000 | $7.77 | $349.6K | 2,065,102 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-02 | 2022-02-04 | 58,000 | $7.77 | $450.7K | 92,202 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-02 | 2022-02-04 | 22,000 | $7.77 | $170.9K | 22,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2021-12-03 | 2021-12-06 | 19,977 | $9.22 | $184.2K | 8,149,394 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2021-12-02 | 2021-12-06 | 30,023 | $9.45 | $283.7K | 8,129,417 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2021-11-24 | 2021-11-29 | 2,202 | $13.19 | $29.0K | 34,202 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2021-11-23 | 2021-11-24 | 20,000 | $12.54 | $250.8K | 32,000 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-08-20 | 2021-09-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion deriv | 2021-07-29 | 2021-08-02 | 1,361,069 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion deriv | 2021-07-29 | 2021-08-02 | 1,669,303 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion deriv | 2021-07-29 | 2021-08-04 | 1,361,069 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion deriv | 2021-07-29 | 2021-08-04 | 1,669,303 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2021-07-29 | 2021-07-29 | 20,000 | $7.30 | $146.0K | 56,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion | 2021-07-29 | 2021-08-02 | 553,752 | — | $0 | 553,752 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion | 2021-07-29 | 2021-08-02 | 679,158 | — | $0 | 679,158 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2021-07-29 | 2021-08-04 | 1,625,000 | $8.00 | $13.00M | 1,681,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion | 2021-07-29 | 2021-08-04 | 679,158 | — | $0 | 679,158 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion | 2021-07-29 | 2021-08-04 | 553,752 | — | $0 | 553,752 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2021-07-27 | 2021-07-29 | 36,000 | $7.36 | $265.0K | 36,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion deriv | 2021-07-06 | 2021-07-08 | 1,315,969 | — | $0 | 0 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion deriv | 2021-07-06 | 2021-07-08 | 657,985 | — | $0 | 0 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion deriv | 2021-07-06 | 2021-07-08 | 1,634,515 | — | $0 | 0 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | P Buy | 2021-07-06 | 2021-07-08 | 312,500 | $16.00 | $5.00M | 3,352,693 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion | 2021-07-06 | 2021-07-08 | 657,985 | — | $0 | 657,985 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion | 2021-07-06 | 2021-07-08 | 2,950,484 | — | $0 | 3,040,193 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2021-06-17 | 2021-06-21 | 15,500 | — | $0 | 15,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2021-05-14 | 2021-05-17 | 12,000 | $20.98 | $251.8K | 12,000 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2021-04-13 | 2021-04-15 | 198,413 | $2.52 | $500.0K | 737,646 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2021-03-25 | 2021-03-29 | 739,830 | $14.75 | $10.91M | 739,830 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-03-24 | 2021-03-26 | 21,385 | — | $0 | 21,385 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2020-11-18 | 2020-11-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 10,963 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 1,843,193 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 3,006,155 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 2,008,158 | — | $0 | 2,008,158 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 3,275,205 | — | $0 | 3,275,205 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 11,944 | — | $0 | 2,020,102 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2020-09-23 | 2020-09-25 | 31,000 | — | $0 | 31,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2020-08-20 | 2020-08-21 | 20,000 | $9.09 | $181.8K | 8,099,394 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2020-08-18 | 2020-08-19 | 10,000 | $8.55 | $85.5K | 1,481,719 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2020-08-17 | 2020-08-18 | 6,000 | $6.92 | $41.5K | 1,471,719 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2020-08-14 | 2020-08-17 | 50,000 | $6.51 | $325.5K | 1,465,719 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2020-08-13 | 2020-08-17 | 108,500 | $6.41 | $695.5K | 1,415,719 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | U Tender | 2019-11-12 | 2019-11-12 | 12,979,016 | $27.50 | $356.92M | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | U Tender | 2019-11-12 | 2019-11-12 | 1,783,226 | $27.50 | $49.04M | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-10-10 | 2019-10-10 | 6,900 | $15.05 | $103.8K | 8,079,394 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-10-09 | 2019-10-10 | 8,778 | $14.06 | $123.4K | 8,072,494 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-10-08 | 2019-10-10 | 5,208 | $14.02 | $73.0K | 8,063,716 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2019-08-09 | 2019-08-12 | 28,062 | $15.87 | $445.3K | 12,979,016 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2019-03-07 | 2019-03-08 | 68,000 | $7.48 | $508.6K | 12,950,954 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 2,734 | $11.99 | $32.8K | 8,058,508 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 6,706 | $11.55 | $77.5K | 1,306,308 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 4,258 | $10.41 | $44.3K | 1,299,602 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 911 | $11.99 | $10.9K | 1,307,219 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 20,116 | $11.55 | $232.3K | 8,055,774 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2019-01-07 | 2019-01-07 | 12,775 | $10.41 | $133.0K | 8,035,658 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-21 | 2018-12-21 | 121,666 | $6.44 | $783.5K | 12,876,120 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-21 | 2018-12-21 | 6,834 | $7.10 | $48.5K | 12,882,954 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-20 | 2018-12-20 | 266,631 | $6.17 | $1.65M | 12,754,454 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 10,527 | $14.08 | $148.2K | 8,013,410 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 10,527 | $14.08 | $148.2K | 1,285,871 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 9,418 | $14.94 | $140.7K | 8,022,828 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 9,418 | $14.94 | $140.7K | 1,295,289 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 55 | $15.60 | $858 | 8,022,883 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-13 | 2018-11-14 | 55 | $15.60 | $858 | 1,295,344 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-12 | 2018-11-14 | 5,150 | $13.17 | $67.8K | 7,992,933 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-12 | 2018-11-14 | 5,150 | $13.17 | $67.8K | 1,265,394 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-12 | 2018-11-14 | 9,950 | $13.96 | $138.9K | 8,002,883 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-11-12 | 2018-11-14 | 9,950 | $13.96 | $138.9K | 1,275,344 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-08-10 | 2018-08-14 | 33,000 | $15.08 | $497.6K | 7,787,783 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-06-19 | 2018-08-15 | 200,000 | $15.00 | $3.00M | 7,987,783 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2018-06-19 | 2018-08-15 | 100,000 | $15.00 | $1.50M | 1,260,244 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion deriv | 2018-06-19 | 2018-06-19 | 7,754,783 | — | $0 | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion deriv | 2018-06-19 | 2018-06-19 | 1,132,900 | — | $0 | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion deriv | 2018-06-19 | 2018-06-19 | 256,634 | — | $0 | 0 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion | 2018-06-19 | 2018-06-19 | 7,754,783 | — | $0 | 7,754,783 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion | 2018-06-19 | 2018-06-19 | 1,132,900 | — | $0 | 1,160,244 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | C Conversion | 2018-06-19 | 2018-06-19 | 256,634 | — | $0 | 256,634 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-07 | 2018-06-08 | 3,400 | $28.03 | $95.3K | 12,487,823 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-07 | 2018-06-08 | 6,600 | $27.52 | $181.6K | 12,484,423 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-06 | 2018-06-08 | 17,000 | $28.85 | $490.4K | 12,477,823 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-05 | 2018-06-06 | 46,980 | $26.04 | $1.22M | 12,407,803 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-05 | 2018-06-06 | 53,020 | $26.93 | $1.43M | 12,460,823 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-04 | 2018-06-06 | 11,800 | $24.75 | $292.1K | 12,360,823 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2018-06-04 | 2018-06-06 | 8,200 | $24.02 | $197.0K | 12,349,023 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,905 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 103,478 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 137,154 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,454 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 26,496 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 1,201,160 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 228,752 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 25,293 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-30 | 2,905 | — | $0 | 2,905 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-30 | 1,106 | — | $0 | 228,752 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | J Other | 2017-11-09 | 2017-11-13 | 12,214,953 | — | $0 | 12,340,823 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | J Other | 2017-11-09 | 2017-11-13 | 12,214,953 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-08-16 | 2017-08-17 | 1,379 | $25.62 | $35.3K | 125,770 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-08-16 | 2017-08-17 | 100 | $26.81 | $2.7K | 125,870 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-08-16 | 2017-08-17 | 3,521 | $24.87 | $87.6K | 124,391 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-08-15 | 2017-08-17 | 7,870 | $22.39 | $176.2K | 120,870 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-08-15 | 2017-08-17 | 13,000 | $21.16 | $275.1K | 113,000 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-07-05 | 2017-07-07 | 100,000 | $17.00 | $1.70M | 100,000 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-07-05 | 2017-07-07 | 50,000 | $17.00 | $850.0K | 1,783,226 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-30 | 2017-06-01 | 2,454 | — | $0 | 2,454 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2016-09-13 | 2016-09-15 | 289,855 | $34.50 | $10.00M | 1,201,160 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 137,154 | — | $0 | 137,154 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 130,623 | — | $0 | 130,623 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 137,154 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 130,623 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 1,659,237 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 941 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 8,469 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 8,469 | — | $0 | 227,646 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 1,659,237 | — | $0 | 1,659,237 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 941 | — | $0 | 25,293 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 8,385 | — | $0 | 8,385 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 18,111 | — | $0 | 18,111 | SEC↗ |